Bothell, WA, United States of America

Sergey G Lokhov

This inventor holds 24 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 8 EPO patents, primarily in Nucleic Acid Analysis. Top assignees: Cepheid Corporation, Epoch Biosciences, Inc., Elitech Holding B.v.. Active years: 2004-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sergey G Lokhov. Retrieved from https://idiyas.com/inventor/sergey-g-lokhov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 24 

% Patents Active = 83.3

 

 

Average Co-Inventor Count = 3.1

ph-index = 6

Forward Citations = 215(Granted Patents)


Location History:

  • Kirkland, WA (US) (2004 - 2010)
  • Seattle, WA (US) (2022)
  • Bothell, WA (US) (2017 - 2024)

Company Filing History:


Years Active: 2004-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Thermostable Polymerase
Oligonucleotide Ligands
DNA Polymerases
Nucleic Acid Polymerases
Real-Time Detection Probes
Single Nucleotide Polymorphism
Fluorescent Probes
Modified Oligonucleotides
TM Leveling Methods
PCR Analysis
24 patents (USPTO):Explore Patents

Title: The Innovative Journey of Sergey G. Lokhov

Introduction

Sergey G. Lokhov, an accomplished inventor based in Bothell, Washington, has made significant contributions to the field of molecular biology through his innovative patents. With a total of 12 patents to his name, Lokhov's work primarily focuses on enhancing the functionality of DNA polymerases, which are crucial enzymes in biological processes such as DNA replication and synthesis.

Latest Patents

Among his recent patents, Lokhov has developed methods for the inhibition of DNA polymerases using uracil-DNA glycosylase-cleavable oligonucleotide ligands. This invention provides methods and compositions aimed at activating oligonucleotide aptamer-deactivated DNA polymerases. By modifying the aptamer through the enzymatic activity of uracil-DNA glycosylase, the binding of the oligonucleotide aptamer to the DNA polymerase is reduced or eliminated, thereby enhancing the DNA synthesis activity. The innovation includes exemplary kits that incorporate a DNA polymerase-binding oligonucleotide aptamer and the aforementioned enzymatic activities for specific modifications.

Furthermore, Lokhov's development of methods for inhibiting nucleic acid polymerases through endonuclease V-cleavable circular oligonucleotide ligands showcases his ability to create versatile biotechnology solutions. This invention similarly focuses on activating these polymerases by cleaving the aptamer using endonuclease V, which facilitates enhanced DNA synthesis.

Career Highlights

Sergey G. Lokhov has established himself as a key figure within his organization, Cepheid Corporation. His research and developments contribute significantly to the ongoing efforts in the fields of genetics and molecular diagnostics, enhancing the application of DNA technology.

Collaborations

Lokhov collaborates with notable colleagues such as Igor V. Kutyavin and Alexander A. Gall. These partnerships not only foster innovation but also advance the scientific community's understanding of enzymatic processes and their applications in various fields.

Conclusion

In conclusion, Sergey G. Lokhov exemplifies the spirit of innovation through his groundbreaking patents and collaborative efforts. His contributions to understanding and enhancing DNA polymerases will undoubtedly leave a lasting impact on molecular biology and biotechnology. As he continues to work at Cepheid Corporation, his journey as an inventor is sure to inspire future generations of researchers and innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…